NMRA-335140 for depression symptoms in bipolarity type II
About this title
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
Read the official source — NCT06429722Researchers compared NMRA-335140 80 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Understand this study
What did researchers investigate?
Researchers compared NMRA-335140 80 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Who was this study for?
This study was for people with type II bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Phoenix and 20 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- Neumora Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06429722
- Official title
Show the full official title
A Phase 2a, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With a Major Depressive Episode Associated With Bipolar II Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Phoenix · Little Rock · Garden Grove
18 more locations
- Long Beach
- San Jose
- Torrance
- Gainesville
- Lauderhill
- Maitland
- Miami
- Miami Lakes
- Marietta
- Savannah
- Watertown
- Flowood
- Marlton
- Princeton
- Toms River
- Brooklyn
- Houston
- Bellevue
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared NMRA-335140 80 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Who is behind this study?
The study sponsor is Neumora Therapeutics, Inc.
Did this study involve medication?
Yes. The study involved medication, including NMRA-335140 80 mg and Placebo.
Who was this study for?
This study was for people with type II bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
